Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Neoplasms 1

Interventions

pembrolizumab 3Tirzepatide 2Paclitaxel 2Metformin 2Carboplatin 2tislelizumab 1olaparib 1niraparib 1montelukast 1Taxes 1Tablets 1Radiotherapy, Intensity-Modulated 1Progesterone 1Pafolacianine 1Morphine 1Laparotomy 1Hysterectomy 1Fluorescein 1Ezetimibe 1Dasatinib 1Biopsy 1Atorvastatin 1Anti-Inflammatory Agents, Non-Steroidal 1Anesthesia, Local 1Anesthesia, General 1Anesthesia, Conduction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Endometrial Neoplasms × Hysterectomy × Clear all
NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
3 enrolled
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡